| 臺大學術典藏 |
2021-05-02T03:29:19Z |
Epigenome-wide association study on asthma and chronic obstructive pulmonary disease overlap reveals aberrant DNA methylations related to clinical phenotypes
|
Chen Y.-C.; Tsai Y.-H.; Wang C.-C.; Liu S.-F.; Chen T.-W.; Fang W.-F.; Lee C.-P.; Hsu P.-Y.; Chao T.-Y.; Wu C.-C.; Wei Y.-F.; Chang H.-C.; Tsen C.-C.; Chang Y.-P.; Lin M.-C.; CHONG-JEN YU; Wang H.-C.; Chiang C.-H.; Perng D.-W.; Cheng S.-L.; Hsu J.-Y.; Hsu W.-H.; Hsiue T.-R.; Lin H.-I.; Wang C.-Y.; Chang Y.-C.; Chen C.-M.; Lin C.-S.; Chen L.; Chong I.-W.; Taiwan Clinical Trial Consortium of Respiratory Disease (TCORE) group |
| 臺大學術典藏 |
2021-03-19T06:57:13Z |
Epigenome-wide association study on asthma and chronic obstructive pulmonary disease overlap reveals aberrant DNA methylations related to clinical phenotypes
|
Chen Y.-C.; Tsai Y.-H.; Wang C.-C.; Liu S.-F.; Chen T.-W.; Fang W.-F.; Lee C.-P.; Hsu P.-Y.; Chao T.-Y.; Wu C.-C.; Wei Y.-F.; Chang H.-C.; Tsen C.-C.; Chang Y.-P.; Lin M.-C.; Yu C.-J.; Wang H.-C.; Chiang C.-H.; Perng D.-W.; Cheng S.-L.; Hsu J.-Y.; Hsu W.-H.; Hsiue T.-R.; Lin H.-I.; Wang C.-Y.; YEUN-CHUNG CHANG; Chen C.-M.; Lin C.-S.; Chen L.; Chong I.-W.; Taiwan Clinical Trial Consortium of Respiratory Disease (TCORE) group |
| 國家衛生研究院 |
2021-03-03 |
Epigenome-wide association study on asthma and chronic obstructive pulmonary disease overlap reveals aberrant DNA methylations related to clinical phenotypes
|
Chen, YC;Tsai, YH;Wang, CC;Liu, SF;Chen, TW;Fang, WF;Lee, CP;Hsu, PY;Chao, TY;Wu, CC;Wei, YF;Chang, HC;Tsen, CC;Chang, YP;Lin, MC;Yu, CJ;Wang, HC;Chiang, CH;Perng, DW;Cheng, SL;Hsu, JY;Hsu, WH;Hsiue, TR;Lin, HI;Wang, CY;Chang, YC;Chen, CM;Lin, CS;Chen, L;Chong, IW; Taiwan Clinical Trial Consortium of Respiratory Disease Group |
| 臺大學術典藏 |
2020-08-12T07:47:00Z |
The association between inhaled corticosteroid and pneumonia in COPD patients: The improvement of patients’ life quality with COPD in Taiwan (IMPACT) study
|
Wang C.-Y.; Lai C.-C.; Yang W.-C.; Lin C.-C.; Chen L.; HAO-CHIEN WANG; Yu C.-J.; Taiwan Clinical Trial Consortium for Respiratory Diseases (TCORE) |
| 臺大學術典藏 |
2020-08-12T07:46:59Z |
Severe exacerbation and pneumonia in COPD patients treated with fixed combinations of inhaled corticosteroid and long-acting beta2 agonist
|
Wang Y.-H.; Yang W.-C.; Wang C.-Y.; HAO-CHIEN WANG; Chen L.; Yu C.-J.; Taiwan Clinical Trial Consortium for Respiratory Diseases (TCORE); Yang H.-H.; Lai C.-C. |
| 臺大學術典藏 |
2020-08-12T07:46:59Z |
Impact of selective and nonselective beta-blockers on the risk of severe exacerbations in patients with COPD
|
Huang Y.L.;Lai C.-C.;Wang Y.-H.;Wang C.-Y.;Wang J.-Y.;Hao-Chien Wang;Yu C.-J.;Chen L.;Taiwan Clinical Trial Consortium For Respiratory Diseases (Tcore); Huang Y.L.; Lai C.-C.; Wang Y.-H.; Wang C.-Y.; Wang J.-Y.; HAO-CHIEN WANG; Yu C.-J.; Chen L.; Taiwan Clinical Trial Consortium for Respiratory Diseases (TCORE) |
| 臺大學術典藏 |
2020-08-12T07:46:58Z |
Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin ii receptor blockers on the risk of pneumonia and severe exacerbations in patients with COPD
|
Yu C.-J.; Chen L.; Taiwan Clinical Trial Consortium for Respiratory Diseases (TCORE); Lai C.-C.; Wang Y.-H.; Wang C.-Y.; HAO-CHIEN WANG |
| 臺大學術典藏 |
2020-08-12T07:46:57Z |
Risk of Sepsis and Mortality Among Patients With Chronic Obstructive Pulmonary Disease Treated With Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers
|
Lai C.-C.; Wang Y.-H.; Wang C.-Y.; HAO-CHIEN WANG; Yu C.-J.; Chen L.; Taiwan Clinical Trial Consortium for Respiratory Diseases (TCORE) |
| 臺大學術典藏 |
2020-08-12T07:46:57Z |
Comparison between COPD Assessment Test (CAT) and modified Medical Research Council (mMRC) dyspnea scores for evaluation of clinical symptoms, comorbidities and medical resources utilization in COPD patients
|
Cheng S.-L.; Lin C.-H.; Wang C.-C.; Chan M.-C.; Hsu J.-Y.; Hang L.-W.; Perng D.-W.; Yu C.-J.; HAO-CHIEN WANG; Taiwan Clinical Trial Consortium for Respiratory Disease (TCORE) |
| 臺大學術典藏 |
2020-08-12T06:34:22Z |
Comparison between COPD Assessment Test (CAT) and modified Medical Research Council (mMRC) dyspnea scores for evaluation of clinical symptoms, comorbidities and medical resources utilization in COPD patients
|
Taiwan Clinical Trial Consortium for Respiratory Disease (TCORE); Wang H.-C.; CHONG-JEN YU; Perng D.-W.; Hang L.-W.; Cheng S.-L.; Lin C.-H.; Wang C.-C.; Chan M.-C.; Hsu J.-Y.; Cheng S.-L.;Lin C.-H.;Wang C.-C.;Chan M.-C.;Hsu J.-Y.;Hang L.-W.;Perng D.-W.;Chong-Jen Yu;Wang H.-C.;Taiwan Clinical Trial Consortium For Respiratory Disease (Tcore) |
| 國家衛生研究院 |
2018-10-27 |
The impact of sepsis on the outcomes of COPD patients: A population-based cohort study
|
Chen, CH;Lai, CC;Wang, YH;Wang, CY;Wang, HC;Yu, CJ;Chen, L;Taiwan Clinical Trial Consortium for Respiratory Diseases (TCORE) |
| 國家衛生研究院 |
2017-08-21 |
Severe exacerbation and pneumonia in COPD patients treated with fixed combinations of inhaled corticosteroid and long-acting beta2 agonist
|
Yang, HH;Lai, CC;Wang, YH;Yang, WC;Wang, CY;Wang, HC;Chen, LK;Yu, CJ;Taiwan Clinical Trial Consortium for Respiratory Diseases(TCORE) |
